Conmed Corp.

NYSE:CNMD

54.33

+0.11 (+0.20%)

4:20:00 PM EDT: $54.33 0.00 (0.00%)

Market Cap (Intraday)	1.68B
Current PE	14.18
Forward PE	12.35
2yr Forward PE	11.51

See more stats

Estimates Current Quarter

Revenue	$338.42 Million
Adjusted EPS	$1.12

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Conmed Corp. Stock, NYSE:CNMD

11311 Concept Boulevard, Largo, Florida 33773

United States of America

Phone: +1.727.392.6464

Number of Employees: 3900

http://www.conmed.com

Description

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.